Maintenance Period Research Articles

Cost-Benefit Analysis of Minor Irrigation Tank Rehabilitation Using Run-Off and Storage Capacity: A Case Study from Ambuliyar Sub-Basin, Tamil Nadu, India

This research examines the significance of restoring efficient water management systems in India’s semiarid environment, with special emphasis on the role of traditional irrigation structures, such as tanks, in collecting and storing limited water resources. Assessing the benefits of any restoration program, especially when socioeconomic and environmental benefits are involved, is challenging. In the context of tank rehabilitation, a cost-benefit analysis will be conducted regarding economic and ecological returns in the post-desiltation phase. Since the restoration process requires a significant investment, assessing the project’s viability during the planning stage is better. The present study proposes a novel method to indirectly analyse the cost-benefit of the tank restoration process by correlating run-off and storage capacity of tanks before the planning phase. The Ambuliyar sub-basin, which covers an area of 930 square kilometres in Tamil Nadu, India, comprising 181 tanks (water bodies) of varying sizes and shapes, was taken for this study. This study employed the Soil Conservation Service Curve Number (SCS-CN) method, incorporating factors such as soil type, land cover, land use practices, and advanced remote sensing and Geographic Information System (GIS) tools to simulate surface run-off. Run-off volume and tank capacity were compared for all seasons at the micro-watershed level. The results demonstrated that the run-off volume in each micro-watershed significantly exceeded the tank capacity across all seasons. Even during the summer, the run-off volumes in the micro-watershed were considerably higher than the tank capacity. The findings suggest tank restoration can effectively store run-off and significantly fulfil agricultural and other essential needs throughout the year, thereby improving the local rural economy. This study also highlights the need for periodic maintenance and rehabilitation of these tank systems to retain their functionality.

An analysis of circuit breaker capacity according to IEC 60909 and IEC 60059 standards at the PT Borneo Alumina Indonesia electrical system

At PT Borneo Alumina Indonesia (PT BAI), the D01 Power Distribution System uses circuit breakers (CB) with a current rating capacity of 1250A for both incoming and outgoing 10kV busbars. Replacing outgoing CBs with the same capacity during maintenance leads to unnecessary waste. This study was conducted to examine the appropriate CB capacity as a substitute for the old CBs in the outgoing 10 kV busbars for loads of 10 kV induction motors and transformers so that recommendations can be made to improve efficiency during maintenance on the D01 Power Distribution System. The Electronic Transient Analyzer Program (ETAP) 19.0.1 software was used to perform short circuit simulations based on IEC 60909 and load flow simulations, which were then adjusted to IEC 60059 and CB products from Siemens. The results show that we can replace the current Siemens CB, which has a rated breaking current specification of 31.5kA, with 25kA during the maintenance period. We can also replace the rated peak value of 80kA with 63kA, and the rated current of 1250A with 630A. Replacement of CB specifications does not change/modify the switchgear panel because the replacement CB matches the brand, dimensions, and size of the currently installed CB. These findings would also help increase efficiency during maintenance on the D01 Power Distribution System. The discussion includes limitations and recommendations for future research.

Optimizing maintenance therapy in responders to abrocitinib induction: A post hoc analysis of JADE REGIMEN.

Treatment optimization may require dosing flexibility. The Phase 3 JADE REGIMEN trial (NCT03627767) evaluated maintenance of abrocitinib 200 mg-induced response in patients with moderate-to-severe atopic dermatitis (AD) randomly assigned to subsequent maintenance with continuous-dose abrocitinib (200 mg), reduced-dose abrocitinib (100 mg) or placebo. Maintenance with continuous-dose abrocitinib was associated with a stronger prevention of disease flares, but also with a higher occurrence of adverse events, compared with the reduced dose. This post hoc analysis of JADE REGIMEN aimed to identify predictors of not flaring during the maintenance period and to generate tools that can be used to assess probability of not flaring. Data were analysed from patients who responded to abrocitinib 200 mg induction therapy (12 weeks) and were randomly assigned to receive abrocitinib (200 mg or 100 mg) or placebo in the 40-week maintenance period. Demographic and baseline disease characteristics and level of response to induction were evaluated for association with not flaring using logistic regression. Parameters with a significant (p < 0.15) interaction with the treatment arm were fitted into a multivariable regression model, which was used to assess probability of not flaring. Lower percentage body surface area affected at baseline (p = 0.09), absence of prior exposure to systemic agents (p = 0.02) and greater percentage change in EASI from baseline to randomization (p < 0.001) were identified as predictors of not flaring with abrocitinib. In both abrocitinib arms, percentage change in EASI from baseline to end of induction (Week 12) was the major contributor to the probability of not flaring in the maintenance period. Maintenance of response using reduced-dose abrocitinib 100 mg may be feasible for patients with lower baseline disease severity and strong response to abrocitinib 200 mg induction treatment.

Enhancing maintenance efficiency in energy assets through AI: a case study of maintAI

Energy assets demand periodic regular maintenance to ensure safe, reliable and efficient operations. The dynamic nature of operating conditions and evolving best practices necessitate frequent optimisation of maintenance programs. Traditionally, these programs were labour-intensive and costly to deploy, often yielding unclear outcomes due to subjective decision-making. The advent of artificial intelligence (AI) presents an opportunity to challenge traditional approaches. This paper presents a case study where asset knowledge, data, and AI capabilities are leveraged to streamline maintenance optimisation using our ‘maintAI’ approach. The program addresses maintenance strategy, backlog, spares, and predictive maintenance optimisation with a focus on value creation, data-driven decisions, and consistent recommendations. A systematic methodology employs AI to sift through and eliminate non-value-adding tasks, enabling prioritisation of work and enhancing reliability and productivity throughout the production facility lifecycle. AI, including Natural Language Processing and Generative AI algorithms, enhances the speed and accuracy of failure mode classification from operational maintenance data. Reliability modelling techniques provide insights into equipment reliability. Recommendations undergo expert review before integration into a Computerised Maintenance Management System. Implementation of this data-driven approach demonstrates rapid deployment and sustained efficiency, yielding substantial gains in production uptime, cost reduction, and safety. The user-centric design ensures agility and ease of configuration. A recent project, which took only 6 weeks to deliver, led to a ~28% reduction in maintenance backlog, freeing capacity for critical focus areas. The maintAI approach proves a meaningful change for energy producers, offering a new solution in maintenance optimisation for enhanced reliability and productivity.

Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study

ELEVATE (Study 410; NCT03288129) is the first prospective, multicenter, open-label, Phase IV study of perampanel as monotherapy or first adjunctive therapy in patients aged ≥ 4 years with focal-onset seizures or generalized tonic–clonic seizures in the United States. The study included Screening, Titration (≤ 13 weeks), Maintenance (39 weeks), and Follow-up (4 weeks) Periods. During Titration, perampanel was initiated at 2 mg/day and up-titrated to 4 mg/day at Week 3. Depending on response and tolerability, optional up-titrations to a maximum of 12 mg/day occurred. The primary endpoint was retention rate; additional endpoints included seizure-freedom rate, 50% responder rate, and incidence of treatment-emergent adverse events (TEAEs). At baseline, 10 (18.5%) patients were assigned to the monotherapy group and 44 (81.5%) patients to the first adjunctive therapy group. However, due to the addition of an anti-seizure medication along with perampanel on the first day of treatment, one patient was excluded from the monotherapy subgroup analyses. The mean perampanel exposure duration was 39.8 weeks and 32 (59.3%) patients completed the study. Retention rate at 12 months (or study completion) was 63.0% (monotherapy, 77.8%; first adjunctive therapy, 59.1%). Seizure-freedom rate during the Maintenance Period was 32.7% (monotherapy, 44.4%; first adjunctive therapy, 29.5%) and the 50% responder rate was 78.7% (monotherapy, 85.7%; first adjunctive therapy, 76.9%). TEAEs and serious TEAEs were reported by 88.9% (n = 48/54) and 7.4% (n = 4/54) of patients, respectively. Overall, the efficacy and safety of perampanel as monotherapy or first adjunctive therapy support the use of perampanel as early-line treatment for epilepsy.

Konservasi Eksosistem Pesisir Dan Pendidikan Lingkungan Melalui Pembibitan Mangrove Oleh Mahasiswa

This writing reviews the implementation of a student service program that focuses on mangrove nurseries, with the aim of supporting conservation through environmental education. The nursery process involves preparing the land, collecting mangrove propagules, and transferring the seedlings to the nursery. These steps aim to support ecological awareness among university students, so that they can become a generation that cares about the environment and understands Indonesia's strategic role as a maritime nation. This research also emphasizes the importance of periodic monitoring and maintenance of mangrove seedlings to ensure healthy and sustainable growth. The results of this study provide a practical view of the contribution of higher education in the formation of maritime character and ecological awareness through mangrove nurseries. The implication is to strengthen maritime character and increase ecological awareness among students and Indonesian society more broadly.

Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study.

Paroxysmal movement disorders are common in Glut1 deficiency syndrome (Glut1DS). Not all patients respond to or tolerate ketogenic diets. The objective was to evaluate the effectiveness and safety of triheptanoin in reducing the frequency of disabling movement disorders in patients with Glut1DS not receiving a ketogenic diet. UX007G-CL301 was a randomized, double-blind, placebo-controlled, phase 3 crossover study. After a 6-week run-in, eligible patients were randomized 1:1 to the first sequence (triheptanoin/placebo or placebo/triheptanoin) titration plus maintenance, followed by washout and the opposite sequence titration plus maintenance. The placebo (safflower oil) matched the appearance, taste, and smell of triheptanoin. Open-label triheptanoin was administered in the extension. The frequency of disabling paroxysmal movement disorder events per 4 weeks (recorded by diary during maintenance; primary endpoint) was assessed by Wilcoxon rank-sum test. Forty-three patients (children, n = 16; adults, n = 27) were randomized and treated. There was no difference between triheptanoin and placebo in the mean (interquartile range) number of disabling paroxysmal movement disorder events (14.3 [4.7-38.3] vs. 11.8; [3.2-28.7]; Hodges-Lehmann estimated median difference: 1.46; 95% confidence interval, -1.12 to 4.36; P = 0.2684). Treatment-emergent adverse events were mild/moderate in severity and included diarrhea, vomiting, upper abdominal pain, headache, and nausea. Two patients discontinued the study because of non-serious adverse events that were predominantly gastrointestinal. The study was closed early during the open-label extension because of lack of effectiveness. Seven patients continued to receive triheptanoin compassionately. There were no significant differences between the triheptanoin and placebo groups in the frequency of disabling movement disorder events during the double-blind maintenance period. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Role of the prefrontal cortex in musical and verbal short-term memory: A functional near-infrared spectroscopy study

Abstract Auditory short-term memory (STM) is a key process in auditory cognition, with evidence for partly distinct networks subtending musical and verbal STM. The delayed matching-to-sample task (DMST) paradigm has been found suitable for comparing musical and verbal STM and for manipulating memory load. In this study, musical and verbal DMSTs were investigated with measures of activity in frontal areas with functional near-infrared spectroscopy (fNIRS): Experiment 1 compared musical and verbal DMSTs with a low-level perception task (that does not entail encoding, retention, or retrieval of information), to identify frontal regions involved in memory processes. Experiment 2 manipulated memory load for musical and verbal materials to uncover frontal brain regions showing parametric changes in activity with load and their potential differences between musical and verbal materials. A FIR model was used to deconvolute fNIRS signals across successive trials without making assumptions with respect to the shape of the hemodynamic response in a DMST. Results revealed the involvement of the dorsolateral prefrontal cortex (dlPFC) and inferior frontal gyri (IFG), but not of the superior frontal gyri (SFG) in both experiments, in keeping with previously reported neuroimaging data (including fMRI). Experiment 2 demonstrated a parametric variation of activity with memory load in bilateral IFGs during the maintenance period, with opposite directions for musical and verbal materials. Activity in the IFGs increased with memory load for verbal sound sequences, in keeping with previous results with n-back tasks. The decreased activity with memory load observed with musical sequences is discussed in relation to previous research on auditory STM rehearsal strategies. This study highlights fNIRS as a promising tool for investigating musical and verbal STM not only for typical populations, but also for populations with developmental language disorders associated with functional alterations in auditory STM.

Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced Therapies

The pivotal phase 3 True North (TN) study demonstrated the efficacy and safety of ozanimod in patients with moderately to severely active ulcerative colitis. This analysis assessed ozanimod during TN and the ongoing open-label extension (OLE) in patients with active disease who were naive to advanced therapies (ATs). TN was a randomized, double-blind, placebo-controlled trial consisting of 10-week induction period and 42-week maintenance period. Eligible patients could enter the OLE. Symptomatic efficacy was evaluated from induction through the OLE. Clinical, endoscopic, and mucosal outcomes were evaluated at the end of induction (Week [W] 10) and maintenance (W52) and at predefined OLE timepoints (OLE W46 and W94). Safety during TN was reported. This analysis included 616 AT-naive patients. Numerically greater proportions of patients receiving ozanimod than placebo achieved symptomatic response (39% vs 29%, 95% confidence interval, -0.1 to 18.8) by W2, with significant differences (56% vs 39%, 95% confidence interval, 6.3-26.3) achieved by W4. Patients receiving ozanimod showed significant improvements across efficacy outcomes versus placebo at W10 and W52 (P < .05, all endpoints). In patients on continuous ozanimod who entered the OLE in clinical response at W52, 91% maintained clinical response through OLE W94, and 74% achieved endoscopic improvement and 57% achieved mucosal healing at OLE W94. In ozanimod-treated patients without clinical response by W10 who received extended induction in the OLE, 62% achieved symptomatic response by OLE W10. Safety outcomes in AT-naive patients were consistent with the total TN population. Ozanimod is an effective, durable, and well-tolerated oral therapy for AT-naive ulcerative colitis patients. gov, numbers NCT02435992 and NCT02531126.

A novel AI-powered method for robust identification of operational phases in refrigerators

Refrigerators are essential appliances in our daily lives, while the accurate identification of their operational phase is crucial for various applications, such as energy management and maintenance. This paper introduces a novel method to predict the operational phase of refrigerators based on power consumption data, exploiting artificial intelligence (AI) and pattern recognition techniques. Specifically, the proposed method initially identifies the driving speed of the compressor (fixed or variable speed) utilizing an Adaptive Boosting, (AdaBoost) classifier. Following that, a Long Short-Term Memory (LSTM) classifier was designed for each type of compressor based on extracted statistical features. This classifier is used to categorize daily power consumption into the different operational phases. Moreover, the proposed AI-driven diagnostic tool facilitates operational-based prescriptive maintenance by addressing periodic and phase-specific maintenance actions while providing homeowners with informed suggestions on alternative refrigerator models that offer greater cost savings and reduced annual energy consumption. The proposed method was tested on real and simulated data for over 20 years, with the AdaBoost classifier achieving an accuracy close to 97% and an F1 score close to 97% and the LSTM nodes achieving an accuracy of approximately 95% in all cases. Finally, the method demonstrated robustness when applied to new datasets, showing comparable performance on unknown data, rendering it a powerful tool for refrigerator management and maintenance.

Management of Endo-Perio lesion in a Tooth with an Unfavorable Prognosis: a Clinical Case Report with an 18-Month Follow-Up

The aim of this case study is to report a successful clinical case of an endo-perio lesion in a tooth with an initially unfavorable prognosis, followed up for 18 months. A male patient, public servant, non-smoker, without a history of diabetes, and married sought dental treatment in 1995 due to periodontal problems. He was then 40 years old and diagnosed with moderate to advanced periodontal disease. The initial treatment consisted of supra and subgingival scaling, followed by the extraction of teeth indicated for removal. After discharge, the patient adhered to a preventive periodic maintenance (PPM) program to control periodontal disease recurrence. In 2021, tooth 43 showed an unfavorable endo-perio lesion during a routine check-up. Despite treatment options, the patient opted for conservative treatment with endodontic and periodontal procedures. Simultaneously, PPM sessions were performed. The patient was monitored every six months, showing regression of periodontal pockets and significant improvement after 18 months. This case highlights the importance of patient adherence to PPM, demonstrating that a conservative approach and proper maintenance can lead to positive clinical outcomes even in cases with an initially unfavorable prognosis.

High-radiation-exposure tasks in Korean pressurized heavy-water reactors.

This study analysed the occupational dose in Korean pressurized heavy-water reactors (PHWRs) and identified tasks involving high radiation exposure. The average individual dose was sufficiently low to be below the annual effective dose limit for radiation workers and is even lower than the dose limit for the general public. However, some workers received relatively higher doses than others. Furthermore, most PHWR workers are exposed to radiation during planned maintenance periods. In this study, the radiation dose was normalized (radiation dose per unit time) to determine the high-radiation-exposure tasks in Korean PHWRs. Consequently, end-fitting lapping, delayed neutron tube work and fuel channel fixed-end change tasks were identified as high-radiation-exposure tasks in Korean PHWRs. If appropriate radiation protection measures are prioritized for the identified high-dose exposure tasks, optimization of radiological protection will be effectively achieved by reducing the dose that is relatively higher than the average.

Long-Term Improvement in Cardiorespiratory Fitness Ameliorates Insulin Sensitivity beyond Changes in Visceral/Ectopic Fat among Men with Visceral Obesity.

The SYNERGIE study documented the effects on cardiometabolic risk (CMR) indices of a 1-year lifestyle intervention targeting physical activity (PA) and diet followed by a 2-year maintenance period in men with visceral obesity. Improvements in CMR markers and a decrease in low-attenuation muscle (LAM) area were observed after 1 year. Despite a rebound in visceral adipose tissue (VAT) during the maintenance period, insulin resistance (IR) improved. We tested the hypothesis that variations in cardiorespiratory fitness (CRF) and LAM could explain the long-term improvement in IR. A health (n = 88; mean age 49.0 ± 8.2 years) and fitness (n = 72) evaluation was performed at 0, 1, and 3 years. Participants were classified into two groups based on their CRF response over the maintenance period (worsening: CRF- vs. maintenance/improvement: CRF+). During the maintenance period, changes in the psoas and core LAM areas correlated with changes in IR (r = 0.27; p < 0.05 and r = 0.34; p < 0.005) and changes in CRF (r = -0.31; p < 0.01 and r = -0.30; p < 0.05). IR improved in the CRF+ group (p < 0.05) but remained stable in the CRF- group. Men in the CRF+ group regained half of the changes in VAT volume and LAM at the psoas and mid-thigh compared to the CRF- group (p < 0.05). These results support the importance of targeting VAT and CRF/PA for the long-term management of CMR in men with visceral obesity.

Status update of the ATLAS ECR ion sources at Argonne National Laboratory

The Argonne Tandem Linac Accelerator System (ATLAS) at Argonne National Laboratory (ANL) typically operates 24/7 with weekly ion beam changes and an annual 1 month maintenance period. Due to recent installations and upgrades at ATLAS, user demands for new beams and higher intensities have expanded an already diverse operational envelope of both electron cyclotron resonance ion sources (ECRIS), ECR2 and ECR3. A variety of material introduction techniques including sputter, oven, reduction and gas feed were used to meet the challenge of an intense run schedule. With two ECRIS available to feed the accelerator, beam development and preparation were able to occur concurrently with ATLAS programmatic activities. Highlights of operational experiences and improvements with ECR2 and ECR3 over the last 2 years are presented.

Long-term effects of adjunctive eslicarbazepine acetate in adult Asian patients with refractory focal seizures: Post hoc analysis of a phase III trial.

A post hoc analysis of data from Asian patients included in the study BIA-2093-304 was conducted to evaluate the long-term safety/tolerability and efficacy of adjunctive eslicarbazepine acetate (ESL) in adult Asian patients with refractory focal seizures. Part I was a randomized controlled trial, in which patients received ESL (800 or 1200 mg once daily [QD]) or placebo, assessed over a 12-week maintenance period. Patients completing Part I could enter two open-label extension periods (Part II, 1 year; Part III, ≥2 years), during which all received ESL (400-1600 mg QD). Safety/tolerability was assessed by evaluating treatment-emergent adverse events (TEAEs). Efficacy assessments included responder and seizure freedom rates. The safety population included 125, 92, and 23 Asian patients in Parts I, II, and III, respectively. Incidence of ESL-related TEAEs was 61.3%, 45.7%, and 17.4% during Parts I, II, and III, respectively. ESL-related TEAEs (most commonly, dizziness, somnolence, and headache) were consistent with ESL's known safety profile. During Part I, responder rates were higher with ESL 800 (41.7%) and 1200 mg QD (44.4%) versus placebo (32.6%), although not statistically significant. Seizure freedom rates with ESL 800 (5.5%) and 1200 mg QD (11.1%) were also higher versus placebo (0%) (p < 0.05 for ESL 1200 mg QD versus placebo). At the end of Part II, responder and seizure freedom rates were 60.3% and 14.7%, respectively. In summary, adult Asian patients with refractory focal seizures were responsive to treatment with ESL as adjunctive therapy and generally showed treatment tolerance well for up to 3 years. No new/unexpected safety findings were observed.

Electrical Ground Fault Monitoring System Utilizing Arduino and Android Application

Abstract: The increasing residential fire incidence caused by electrical ground faults worldwide challenges present and future researchers to develop a system capable of mitigating its occurrence. The absence of periodic equipment maintenance and monitoring facilities leads to potential electrical hazards to humans and properties. However, technological advances have made online electrical ground fault monitoring equipment possible. Users can now remotely gain information regarding the operational condition of electrical equipment in their homes. This paper presents the developed Electrical Ground Fault Monitoring System using Arduino with Android Application (EGFMSAAA), which can detect and transmit electrical ground fault parameters and safety precautions. This study developed a ground fault detector and a mobile application for the monitoring system.

Evolution of therapeutic management of patients with ANCA associated vasculitis in France after licensing Rituximab use

IntroductionIn 2013, rituximab was approved in France for the treatment of ANCA-associated vasculitis (AAV). The aim of the study was to compare the treatment and health events of adult incident patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), included before rituximab approval (over 2010–2012, Group 1) and those included after rituximab approval (over 2014–2017, Group 2).MethodData were extracted from the French National Health Insurance database (SNDS) including outpatient health care consumption and hospital discharge forms. Comparisons between inclusion periods were performed using Wilcoxon and χ² tests. Kaplan-Meier method was used to model the duration of treatment induction, maintenance, and off-drug periods. Fine and Gray tests were used to compare treatment phase durations.ResultsA total of 694 GPA and 283 MPA patients were included in Group 1, while 668 GPA and 463 MPA patients were included in Group 2. Between the two inclusion periods, the proportions of patients treated with rituximab increased in the induction and maintenance phases whereas treatment with azathioprine declined. These proportions remained stable in the case of methotrexate, cyclophosphamide, and glucocorticoid-treated patients. Frequency of first-time hospitalized infections, diabetes and renal failure during the first year after inclusion increased for both groups.Limitations of the studyThis is a retrospective study based on claims data including only 76% of people covered by health insurance in France. The period studied includes the learning phase of using rituximab. This study lacks biological data and precise quantitative analysis for the use of steroids, therefore the criteria for establishing diagnosis and therapeutic choice were unknown.ConclusionsIntroduction of rituximab reduced the use of azathioprine without affecting the use of glucocorticoids or cyclophosphamide.

Micro-mechanical behavior of stone-blowing in ballast maintenance using DEM-CFD coupling method

Stone-blowing restores the track geometry by blowing small crushed stones into the bottom of the sleeper, extending the maintenance period. In this study, ballast and filling stones were modelled using discrete element method (DEM), while the air blowing was simulated using computational fluid dynamics (CFD). The DEM-CFD coupled model has been used to simulate the stone-blowing process and investigate the optimal operation parameters from a micro view.The disturbance of ballast bed during stone-blowing process was analyzed. Meanwhile, the effect of air velocity and tube layouts on the stone-blowing, as well as the sleeper settlement after stone-blowing were discussed. The results show that the maximum disturbance occurs in the inserting area between sleepers, and the disturbance increased with faster insertion speed. It was suggested that the inserting speed of the tube is 0.4 m/s. When the air velocity of stone-blowing was not less than 20 m/s, the blowing quality meets the requirement. Furthermore, the four-tubed stone-blowing approach distributed filling stones more evenly under the sleeper, and reduced the risk of tube blockage. After stone-blowing, the contact number between the bottom of the sleeper and the ballast is greatly increased, reaching 217.9 % after double cross tubes, and 245 % after four tubes stone-blowing. The crushed stone blown in greatly improves the stress distribution of the ballast bed and makes the load transfer more uniform. Overall, this study provides valuable insights into the stone-blowing process and can help optimize the stone-blowing parameters for efficient and effective track maintenance.

Research on joint scheduling method of order grading and machine maintenance

AbstractIn the multi‐variety and large‐scale order production mode, enterprises must balance delivery deadlines and maintain customer satisfaction while also considering the health status of machines. Therefore, the authors propose a method for jointly optimising production scheduling and machine maintenance. Before machine processing, an order value grading and sorting model and a machine health‐status group partitioning model are constructed to classify orders into different production value levels and machines into different health‐status groups, respectively. During machine processing, based on the Weibull distribution theory, a ‘health evaluation function value’ constraint machine preventive maintenance (PM) model and PM strategy are proposed to account for the changing health status of machines; these are integrated with the order allocation machine strategy as decision‐making elements in the production schedule. Finally, two case studies are used to verify the effectiveness of this proposed model and method. The results show that compared to general scheduling schemes, the proposed method can reduce total delay and improve customer satisfaction. Additionally, the PM plan proposed in this method can improve production efficiency and line stability compared to periodic maintenance.

P165 Sustained improvement in clinical outcomes and long-term safety of bimekizumab in patients across the spectrum of axial spondyloarthritis up to week 52: results from two phase 3 studies

Abstract Background/Aims Bimekizumab (BKZ), a monoclonal IgG1 antibody that selectively inhibits IL-17F in addition to IL-17A, has shown rapid and clinically meaningful improvements in disease activity across the axial spondyloarthritis spectrum (axSpA; active non-radiographic axSpA [nr-axSpA; BE MOBILE 1, NCT03928704] and ankylosing spondylitis [AS] / radiographic axSpA [r-axSpA; BE MOBILE 2, NCT03928743]). Here we present outcomes from these two phase 3 studies up to Week (Wk)52. Methods BE MOBILE 1 and 2 have similar study designs: 16-Wk double-blind period followed by 36-Wk maintenance period. Patients were randomised (1:1 in BE MOBILE 1; 2:1 in BE MOBILE 2) to BKZ 160 mg every 4Wks (Q4W) or placebo (PBO). All patients received BKZ 160 mg Q4W from Wk16 up to Wk52. Sustained improvements in ASAS40, BASDAI50 responses, BASDAI, BASFI and ASDAS-CRP scores were assessed up to Wk52. Missing data were imputed using non-responder or multiple imputation for binary and quantitative variables, respectively. Results 254 nr-axSpA (BKZ: 128; PBO: 126) and 332 r-axSpA (BKZ: 221; PBO: 111) patients were randomised; 86.6% and 89.8% completed Wk52, respectively. ASAS40 responses increased from Wk16 to Wk52 with similar efficacy across TNF-naïve/IR patients (Table). Approximately 47% of patients on BKZ achieved BASDAI50 at Wk16, increasing to ∼54% at Wk52 (NRI, Table). All improvements at Wk16 in BASDAI, BASFI and ASDAS were sustained up to Wk52 (Table). Efficacy was similar between treatment arms at Wk52. During the overall study period, 75% (183/244, nr-axSpA) and 75.5% (249/330, r-axSpA) patients reported ≥1 treatment-emergent adverse events (TEAEs). Most common TEAEs included nasopharyngitis, upper respiratory tract infection and oral candidiasis. Incidence of serious TEAEs were low (3.7% [nr-axSpA] and 6.1% [r-axSpA]); no incidence of systemic candidiasis, adjudicated MACE or deaths were reported. ‘Any definite or probable adjudicated IBD TEAE’ was reported in 0.8% (2/240, nr-axSpA) and 0.6% (2/326, r-axSpA) patients with no history of IBD and 25% (1/4, r-axSpA) patients with prior history of IBD. Incidence of uveitis (1.2% [3/244, nr-axSpA]; 2.1% [7/330, r-axSpA]) was low. Conclusion Across the axSpA disease spectrum, bimekizumab demonstrated sustained improvements in clinical outcomes up to Wk52 with no new safety signals. Disclosure K. Gaffney: Shareholder/stock ownership; KG is a shareholder of Rheumatology events. Grants/research support; KG received grant/research support from NASS, Versus Arthritis, AbbVie, Pfizer, UCB Pharma, Novartis, Lilly, Cellgene, Celltrion, Janssen, Gilead and Biogen. Other; KG has received honoraria/ consultation fees from Novartis, AbbVie, UCB Pharma, Lilly and Pfizer, KG has received speaker’s bureau from Novartis, UCB Pharma, AbbVie and Lilly; meeting expenses from AbbVie, Lilly, Roche, Novartis, Pfizer and UCB Pharma. N.D. McKay: Other; NDM received travel fees from UCB Pharma and Gilead, and Speaker’s bureau from Gilead. R. Sengupta: Grants/research support; RS received grants/ research support from AbbVie, Celgene, Novartis and UCB Pharma. Other; RS recevied honoraria or consultancy fees from Abbvie, Biogen, Novartis, Celgene, Lilly, Chugai, MSD and UCB Pharma, RS is on the advisory boards for AbbVie, Biogen, Chugai, Lilly, Novartis and UCB Pharma. C. Fleurinck: Other; CF is an employee of UCB Pharma. C. de la Loge: Consultancies; CdlL is a consultant to UCB Pharma, Brussels, Belgium. U. Massow: Other; UM is an employee of UCB Pharma. V. Taieb: Other; VT is an employee of UCB Pharma. S. Zhao: Honoraria; SSZ received honoraria from UCB Pharma. H. Marzo-Ortega: Grants/research support; HMO received grants/research support from Janssen, Novartis and UCB Pharma. Other; HMO received honoraria and/or consultancy and/or speaker fees from Abbvie, Biogen, Celgene, Janssen, Eli-Lilly, Moonlake, Novartis, Pfizer and UCB Pharma.